Abstract:Ursolic acid (UA) is a natural product which has been shown to possess a wide range of pharmacological activities, in particular those with anticancer activity. In this study, 13 novel ursolic acid derivatives were designed and synthesized in an attempt to further improve compound potency. The structures of the newly synthesized compounds were confirmed using mass spectrometry, infrared spectroscopy, and (1) H NMR. The ability of the UA derivatives to inhibit cell growth was assayed against both various tumor cell lines and a non-pathogenic cell line, HELF. Analysis of theoretical toxicity risks for all derivatives was performed using OSIRIS and indicated that the majority of compounds would present moderate to low risks. Pharmacological results indicated that the majority of the derivatives were more potent growth inhibitors than UA. In particular, 5b demonstrated IC50 values ranging from 4.09 ± 0.27 to 7.78 ± 0.43 μm against 12 different tumor cell lines. Flow cytometry analysis indicated that 5b induced G0/G1 arrest in three of these cell lines. These results were validated by structural docking studies, which confirmed that UA could bind to cyclins D1 (Cyc D1) and cyclin-dependent kinases (CDK6), the key regulators of G0/G1 transition in cell cycle, while the piperazine moiety of 5b could bind with glucokinase (GK), glucose transporter 1 (GLUT1), and ATPase, which are the main proteins involved in cancer cell metabolism. Acridine orange/ethidium bromide staining confirmed that 5b was capable of inducing apoptosis and decreasing cell viability in a dose-dependent manner.

Synthesis and Anti-angiogenesis Activities of Ursolic Acid Derivatives

Synthesis and Anti-Tumor Activity of Derivatives of Ring A of Ursolic Acid

Synthesis and Antitumor Activity Evaluation of Novel Ursolic Acid Derivatives

In Vitro and in Vivo Anticancer Activity Evaluation of Ursolic Acid Derivatives

The Synthesis of Ursolic Acid Derivatives with Cytotoxic Activity and the Investigation of Their Preliminary Mechanism of Action.

Synthesis and Biological Evaluation of Novel Ursolic acid Derivatives as Potential Anticancer Prodrugs

Synthesis and antitumor activity of novel quinoline derivatives of ursolic acid

Synthesis, Characterization and Cytotoxic Activity of Novel Oleanolic Acid and Ursolic Acid Derivatives

Synthesis and evaluation as potential antitumor agents of novel ursolic acid derivatives

Synthesis and cytotoxicity of novel ursolic acid derivatives containing an acyl piperazine moiety.

Synthesis and Evaluation of the HIF-1α Inhibitory Activities of Novel Ursolic Acid Tetrazole Derivatives.

Synthesis and Evaluation of Ursolic Acid Derivatives As Potent Cytotoxic Agents.

Synthesis of Flavone Derivatives via N-Amination and Evaluation of Their Anticancer Activities

ChemInform Abstract: in Vitro and in Vivo Anticancer Activity Evaluation of Ursolic Acid Derivatives.

Design, Synthesis, and Biological Evaluation of Novel Nitrogen Heterocycle-Containing Ursolic Acid Analogs as Antitumor Agents

Synthesis, Biological Activity, ADME and Molecular Docking Studies of Novel Ursolic Acid Derivatives as Potent Anticancer Agents

Synthesis and biological evaluation of N-(4-hydroxy-3-mercaptonaphthalen-1-yl)amides as inhibitors of angiogenesis and tumor growth.

Synthesis and biological evaluation of ursolic acid derivatives containing an aminoguanidine moiety

Design, synthesis, and evaluation of novel ursolic acid derivatives as HIF-1α inhibitors with anticancer potential

Synthesis and Characterization of Ursolic Acid Derivatives, and the Study on the Antibacterial Activity

Ursolic Acid-Based Derivatives as Potential Anti-Cancer Agents: An Update